Johnson & Johnson (J&J) has announced an agreement to acquire Abbott Medical Optics (AMO), a wholly-owned division of Abbott Laboratories, for $4.325 billion. The deal is expected to be finalized by the first quarter of 2017, and to be modestly accretive immediately to adjusted earnings per share, J&J said. Abbott ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.